These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
777 related items for PubMed ID: 25401491
1. Pentraxin 3 as a biomarker of local inflammatory response to vascular injury in systemic lupus erythematosus. Cieślik P, Hrycek A. Autoimmunity; 2015 Jun; 48(4):242-50. PubMed ID: 25401491 [Abstract] [Full Text] [Related]
2. Circulating endothelial cells, endothelial apoptosis and soluble markers of endothelial dysfunction in patients with systemic lupus erythematosus-related vasculitis. Kluz J, Kopeć W, Jakobsche-Policht U, Adamiec R. Int Angiol; 2009 Jun; 28(3):192-201. PubMed ID: 19506538 [Abstract] [Full Text] [Related]
3. Pentraxin-3 levels are associated with vasculitis and disease activity in childhood-onset systemic lupus erythematosus. Sahin S, Adrovic A, Barut K, Durmus S, Gelisgen R, Uzun H, Kasapcopur O. Lupus; 2017 Sep; 26(10):1089-1094. PubMed ID: 28420068 [Abstract] [Full Text] [Related]
4. The impact of anti-endothelial cell antibodies (AECAs) on the development of blood vessel damage in patients with systemic lupus erythematosus: the preliminary study. Cieślik P, Semik-Grabarczyk E, Hrycek A, Holecki M. Rheumatol Int; 2022 May; 42(5):791-801. PubMed ID: 35284968 [Abstract] [Full Text] [Related]
5. Persistent increase in plasma thrombomodulin in patients with a history of lupus nephritis: endothelial cell activation markers. Frijns R, Fijnheer R, Schiel A, Donders R, Sixma J, Derksen R. J Rheumatol; 2001 Mar; 28(3):514-9. PubMed ID: 11296951 [Abstract] [Full Text] [Related]
6. Increased soluble vascular cell adhesion molecule 1 concentrations in patients with primary or systemic lupus erythematosus-related antiphospholipid syndrome: correlations with the severity of thrombosis. Kaplanski G, Cacoub P, Farnarier C, Marin V, Grégoire R, Gatel A, Durand JM, Harlé JR, Bongrand P, Piette JC. Arthritis Rheum; 2000 Jan; 43(1):55-64. PubMed ID: 10643700 [Abstract] [Full Text] [Related]
7. Levels of soluble VCAM-1, soluble ICAM-1, and soluble E-selectin during disease exacerbations in patients with systemic lupus erythematosus (SLE); a long term prospective study. Spronk PE, Bootsma H, Huitema MG, Limburg PC, Kallenberg CG. Clin Exp Immunol; 1994 Sep; 97(3):439-44. PubMed ID: 7521807 [Abstract] [Full Text] [Related]
8. Pentraxin 3 is associated with disease activity but not atherosclerosis in patients with systemic lupus erythematosus. Shimada Y, Asanuma YF, Yokota K, Yoshida Y, Kajiyama H, Sato K, Akiyama Y, Mimura T. Mod Rheumatol; 2014 Jan; 24(1):78-85. PubMed ID: 24261762 [Abstract] [Full Text] [Related]
9. Clinical significance of selected endothelial activation markers in patients with systemic lupus erythematosus. Kuryliszyn-Moskal A, Klimiuk PA, Ciolkiewicz M, Sierakowski S. J Rheumatol; 2008 Jul; 35(7):1307-13. PubMed ID: 18484695 [Abstract] [Full Text] [Related]
10. PTX3 in small-vessel vasculitides: an independent indicator of disease activity produced at sites of inflammation. Fazzini F, Peri G, Doni A, Dell'Antonio G, Dal Cin E, Bozzolo E, D'Auria F, Praderio L, Ciboddo G, Sabbadini MG, Manfredi AA, Mantovani A, Querini PR. Arthritis Rheum; 2001 Dec; 44(12):2841-50. PubMed ID: 11762945 [Abstract] [Full Text] [Related]
11. Relationship between lupus nephritis activity and the serum level of soluble VCAM-1. Ikeda Y, Fujimoto T, Ameno M, Shiiki H, Dohi K. Lupus; 1998 Dec; 7(5):347-54. PubMed ID: 9696139 [Abstract] [Full Text] [Related]
12. Vasculitis in systemic lupus erythematosus (SLE)--assessment of peripheral blood mononuclear cell activation and the degree of endothelial dysfunction: initial report. Kluz J, Kopeć W, Jakobsche U, Prajs I, Adamiec R. Postepy Hig Med Dosw (Online); 2007 Dec 03; 61():725-35. PubMed ID: 18063917 [Abstract] [Full Text] [Related]
13. Biomarkers of endothelial dysfunction in patients with primary focal segmental glomerulosclerosis. Zhang Q, Zeng C, Fu Y, Cheng Z, Zhang J, Liu Z. Nephrology (Carlton); 2012 May 03; 17(4):338-45. PubMed ID: 22295953 [Abstract] [Full Text] [Related]
14. Clinical significance of nailfold capillaroscopy in systemic lupus erythematosus: correlation with endothelial cell activation markers and disease activity. Kuryliszyn-Moskal A, Ciolkiewicz M, Klimiuk PA, Sierakowski S. Scand J Rheumatol; 2009 May 03; 38(1):38-45. PubMed ID: 18991188 [Abstract] [Full Text] [Related]
15. [Assessment of serum levels of adhesion molecules (sICAM-1, sVCAM-1, sE-selectin) in stable and unstable angina and acute myocardial infarction]. Bossowska A, Kiersnowska-Rogowska B, Bossowski A, Galar B, Sowiński P. Przegl Lek; 2003 May 03; 60(7):445-50. PubMed ID: 14750416 [Abstract] [Full Text] [Related]
16. Elevated soluble E-selectin in cutaneous lupus erythematosus. Nyberg F, Stephansson E. Adv Exp Med Biol; 1999 May 03; 455():153-9. PubMed ID: 10599337 [Abstract] [Full Text] [Related]
17. Soluble adhesion molecules in pediatric rheumatic diseases. Bloom BJ, Miller LC, Blier PR. J Rheumatol; 2002 Apr 03; 29(4):832-6. PubMed ID: 11950029 [Abstract] [Full Text] [Related]
18. Circulating soluble adhesion molecules in ANCA-associated vasculitis. Ara J, Mirapeix E, Arrizabalaga P, Rodriguez R, Ascaso C, Abellana R, Font J, Darnell A. Nephrol Dial Transplant; 2001 Feb 03; 16(2):276-85. PubMed ID: 11158400 [Abstract] [Full Text] [Related]
19. Endothelial function and markers of endothelial activation in relation to cardiovascular disease in systemic lupus erythematosus. Svenungsson E, Cederholm A, Jensen-Urstad K, Fei GZ, de Faire U, Frostegård J. Scand J Rheumatol; 2008 Feb 03; 37(5):352-9. PubMed ID: 18666029 [Abstract] [Full Text] [Related]
20. Soluble adhesion molecules (sICAM-1, sVCAM-1) and selectins (sE selectin, sP selectin, sL selectin) levels in children and adolescents with obesity, hypertension, and diabetes. Glowinska B, Urban M, Peczynska J, Florys B. Metabolism; 2005 Aug 03; 54(8):1020-6. PubMed ID: 16092051 [Abstract] [Full Text] [Related] Page: [Next] [New Search]